CapEx at other companies
Other financials
Where this comes from
Reported directly by Edgewise Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The official record: Edgewise Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Edgewise Therapeutics, Inc.'s capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Edgewise Therapeutics, Inc.'s capex?
- Edgewise Therapeutics, Inc. (EWTX) reported capex of $260K in Q1 2026.
- How has Edgewise Therapeutics, Inc.'s capex changed year-over-year?
- Edgewise Therapeutics, Inc.'s capex increased by 490.9% year-over-year, from $44K to $260K.
- What is the long-term trend for Edgewise Therapeutics, Inc.'s capex?
- Over 4 years (2021 to 2025), Edgewise Therapeutics, Inc.'s capex has grown at a -21.3% compound annual growth rate (CAGR), from $668K to $256K.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.